NLRP3 and bacterial infectious disease: In conjunction with previous studies, IL-22 has been shown to inhibit the activation of the NLRP3 inflammasome by suppressing the synthesis of NLRP3 and Caspase-1 proteins, thereby attenuating mammalian bacterial diseases and tissue injury (52, 53).